GLUE
Price
$23.83
Change
-$0.23 (-0.96%)
Updated
Jan 15, 11:33 AM (EDT)
Capitalization
1.83B
56 days until earnings call
Intraday BUY SELL Signals
RVMD
Price
$121.53
Change
+$0.31 (+0.26%)
Updated
Jan 15, 12:07 PM (EDT)
Capitalization
23.44B
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLUE vs RVMD

Header iconGLUE vs RVMD Comparison
Open Charts GLUE vs RVMDBanner chart's image
Monte Rosa Therapeutics
Price$23.83
Change-$0.23 (-0.96%)
Volume$1.32K
Capitalization1.83B
Revolution Medicines
Price$121.53
Change+$0.31 (+0.26%)
Volume$900
Capitalization23.44B
GLUE vs RVMD Comparison Chart in %
GLUE
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLUE vs. RVMD commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and RVMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (GLUE: $24.06 vs. RVMD: $121.22)
Brand notoriety: GLUE and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 71% vs. RVMD: 108%
Market capitalization -- GLUE: $1.83B vs. RVMD: $23.44B
GLUE [@Biotechnology] is valued at $1.83B. RVMD’s [@Biotechnology] market capitalization is $23.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whileRVMD’s FA Score has 1 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • RVMD’s FA Score: 1 green, 4 red.
According to our system of comparison, both GLUE and RVMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 5 TA indicator(s) are bullish while RVMD’s TA Score has 4 bullish TA indicator(s).

  • GLUE’s TA Score: 5 bullish, 4 bearish.
  • RVMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GLUE is a better buy in the short-term than RVMD.

Price Growth

GLUE (@Biotechnology) experienced а +3.35% price change this week, while RVMD (@Biotechnology) price change was +18.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

GLUE is expected to report earnings on Mar 12, 2026.

RVMD is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($23.4B) has a higher market cap than GLUE($1.83B). GLUE (53.444) and RVMD (52.191) have similar YTD gains . GLUE has higher annual earnings (EBITDA): 16.8M vs. RVMD (-1.02B). RVMD has more cash in the bank: 1.93B vs. GLUE (391M). GLUE has less debt than RVMD: GLUE (40.2M) vs RVMD (158M). GLUE has higher revenues than RVMD: GLUE (182M) vs RVMD (0).
GLUERVMDGLUE / RVMD
Capitalization1.83B23.4B8%
EBITDA16.8M-1.02B-2%
Gain YTD53.44452.191102%
P/E Ratio75.16N/A-
Revenue182M0-
Total Cash391M1.93B20%
Total Debt40.2M158M25%
FUNDAMENTALS RATINGS
RVMD: Fundamental Ratings
RVMD
OUTLOOK RATING
1..100
91
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
23
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUERVMD
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 11 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
71%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
USDX25.660.01
+0.02%
SGI Enhanced Core ETF
XDOC33.47N/A
N/A
Innovator US Equity Accelerated ETF - October
PLTY50.79-0.01
-0.02%
YieldMax PLTR Option Income Strategy ETF
JULT45.15-0.10
-0.21%
AllianzIM US Equity Buffer10 Jul ETF
ACIO43.91-0.20
-0.45%
Aptus Collared Investment Opp ETF

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with RVMD. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
+0.29%
RVMD - GLUE
46%
Loosely correlated
+1.06%
KURA - GLUE
43%
Loosely correlated
+1.63%
CRNX - GLUE
41%
Loosely correlated
+2.04%
IMNM - GLUE
41%
Loosely correlated
+3.08%
CCCC - GLUE
40%
Loosely correlated
+0.87%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with NUVL. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+1.06%
NUVL - RVMD
60%
Loosely correlated
+6.59%
ERAS - RVMD
60%
Loosely correlated
+10.73%
CGON - RVMD
54%
Loosely correlated
+5.57%
CRNX - RVMD
53%
Loosely correlated
+2.04%
CLDX - RVMD
50%
Loosely correlated
+1.58%
More